Nonadherence to antipsychotics: The role of positive attitudes towards positive symptoms

被引:29
作者
Moritz, Steffen [1 ]
Huensche, Alexandra [1 ,2 ]
Lincoln, Tania M. [2 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany
[2] Univ Hamburg, Inst Psychol, Hamburg, Germany
关键词
Antipsychotics; Schizophrenia; Adherence; Compliance; COGNITIVE-BEHAVIOR THERAPY; MEDICATION ADHERENCE; SCHIZOPHRENIA; PSYCHOSIS; PREDICTORS; HALLUCINATIONS; BELIEFS; VOICES; DISCONTINUATION; CONSEQUENCES;
D O I
10.1016/j.euroneuro.2014.09.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
psychopharmacological treatment complementary or alternative psychological treatment should be sought because of a largely increased risk of relapse in the case of sudden drug discontinuation. (C) 2014 Elsevier B.V. and ECNP. All rights reserved.Approximately 50-75% of all patients do not take their antipsychotic medication as prescribed. The current study examined reasons why patients continue versus discontinue antipsychotic medication. We were particularly interested to which extent positive attitudes towards psychotic symptoms foster medication nonadherence. An anonymous online questionnaire was set up to decrease response biases. After a strict selection process, 91 participants with schizophrenia spectrum disorders were retained for the final analyses. On average, 6.2 different reasons for nonadherence were reported. Side-effects (71.4%), sudden subjective symptom improvement (52.4%) and forgetfulness (33.3%) emerged as the most frequent reasons for drug discontinuation. Approximately one fourth of all participants (27.3%) reported at least one positive aspect of psychosis as a reason for nonadherence. In contrast, patients reported on average 3.5 different reasons for adherence (e.g., want to live a normal life (74.6%) and fear of psychotic symptoms (49.3%)). The belief that paranoia represents a survival strategy (subscale derived from the Beliefs about Paranoia Scale) was significantly associated with nonadherence. Patients attitudes toward medication and the individual illness model need to be carefully considered when prescribing medication. In particular for patients who are likely to discontinue
引用
收藏
页码:1745 / 1752
页数:8
相关论文
共 50 条
  • [31] ATTITUDES OF CROATIAN PSYCHIATRISTS TOWARDS LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Ciglar, Mirta
    Bjedov, Sarah
    Malekovic, Hrvoje
    [J]. PSYCHIATRIA DANUBINA, 2016, 28 (03) : 273 - 277
  • [32] A two-stage cognitive theory of the positive symptoms of psychosis. Highlighting the role of lowered decision thresholds
    Moritz, Steffen
    Pfuhl, Gerit
    Luedtke, Thies
    Menon, Mahesh
    Balzan, Ryan P.
    Andreou, Christina
    [J]. JOURNAL OF BEHAVIOR THERAPY AND EXPERIMENTAL PSYCHIATRY, 2017, 56 : 12 - 20
  • [33] Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users
    Lapworth, Kely
    Dawe, Sharon
    Davis, Penelope
    Kavanagh, David
    Young, Ross
    Saunders, John
    [J]. ADDICTIVE BEHAVIORS, 2009, 34 (04) : 380 - 385
  • [34] Is smoking linked to positive symptoms in acutely ill psychiatric patients?
    de Beaurepaire, Renaud
    Rat, Pascal
    Beauverie, Patrick
    Houery, Michele
    Niel, Philippe
    Castera, Sophie
    Dagorne, Odile
    Espaze, Renaud
    Giroult, Patrick
    Mahuzier, Georges
    Matheron, Isabelle
    Padovani, Pierre
    Poisson, Nicole
    Richier, Jean-Paul
    Rocher, Jerome
    Ruetsh, Odile
    Touzeau, Didier
    Visinoni, Andre
    Molimard, Robert
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2012, 66 (04) : 225 - 231
  • [35] Mismatch Negativity to Threatening Voices Associated with Positive Symptoms in Schizophrenia
    Chen, Chenyi
    Liu, Chia-Chien
    Weng, Pei-Yuan
    Cheng, Yawei
    [J]. FRONTIERS IN HUMAN NEUROSCIENCE, 2016, 10
  • [36] Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium
    Walton, E.
    Hibar, D. P.
    van Erp, T. G. M.
    Potkin, S. G.
    Roiz-Santianez, R.
    Crespo-Facorro, B.
    Suarez-Pinilla, P.
    Van Haren, N. E. M.
    de Zwarte, S. M. C.
    Kahn, R. S.
    Cahn, W.
    Doan, N. T.
    Jorgensen, K. N.
    Gurholt, T. P.
    Agartz, I.
    Andreassen, O. A.
    Westlye, L. T.
    Melle, I.
    Berg, A. O.
    Morch-Johnsen, L.
    Faerden, A.
    Flyckt, L.
    Fatouros-Bergman, H.
    Jonsson, E. G.
    Hashimoto, R.
    Yamamori, H.
    Fukunaga, M.
    Preda, A.
    De Rossi, P.
    Piras, F.
    Banaj, N.
    Ciullo, V.
    Spalletta, G.
    Gur, R. E.
    Gur, R. C.
    Wolf, D. H.
    Satterthwaite, T. D.
    Beard, L. M.
    Sommer, I. E.
    Koops, S.
    Gruber, O.
    Richter, A.
    Kraemer, B.
    Kelly, S.
    Donohoe, G.
    McDonald, C.
    Cannon, D. M.
    Corvin, A.
    Gill, M.
    Di Giorgio, A.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2017, 135 (05) : 439 - 447
  • [37] Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling
    Carra, Giuseppe
    Crocamo, Cristina
    Angermeyer, Matthias
    Brugha, Traolach
    Toumi, Mondher
    Bebbington, Paul
    [J]. SCHIZOPHRENIA RESEARCH, 2019, 204 : 58 - 64
  • [38] Admission rates, drug attitudes, and psychiatric symptoms in patients of schizophrenia after switching from paliperidone palmitate once-monthly to oral antipsychotics
    Lee, Bong Ju
    [J]. RAWAL MEDICAL JOURNAL, 2021, 46 (04): : 848 - 853
  • [39] The psychopathology of schizophrenia: An integrated view on positive symptoms and negative symptoms
    Moller, HJ
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 : 57 - 64
  • [40] The role of dysfunctional attitudes in models of negative symptoms and functioning in schizophrenia
    Quinlan, Thomas
    Roesch, Scott
    Granholm, Eric
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 157 (1-3) : 182 - 189